Company Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE

IL0011042806

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Other Holding Companies

Inactive Instrument

Clal Biotechnology Industries Ltd (CBI) is an Israel-based biotechnology investment company. CBI's investments are targeted at bio-pharmaceutical companies, which are at different stages of research and development. The Company is a 59%-owned subsidiary of Clal Industries and Investments Ltd. (CII) that is part of IDB group. Clal Biotechnology Industries Ltd. has a number of portfolio companies, namely Andromeda Biotech Ltd., engaged in the field of type 1 diabetes; D-Pharm Ltd and Trombutech, engaged in the field of ischemic stroke; Mediwound Ltd., engaged in burn and wound management; Biokine Ltd, Biocancell Ltd and CureTech, engaged in the field of cancer; Braintact, engaged in the CNS field and Polyheal Ltd, engaged in wound management, among others.

ILS in Million	2021	Weight	2022	Weight	Delta
Investment and Related Activities 100.0 %	132	100.0 %	18	100.0 %	-86.35%

ILS in Million	2021	Weight	2022	Weight	Delta
Israel 100.0 %	132	100.0 %	18	100.0 %	-86.35%

Managers	Title	Age	Since
Assaf Segal CEO	Chief Executive Officer	51	15-06-30
Liat Nissan DFI	Director of Finance/CFO	46	-
Arnon Aharon CTO	Chief Tech/Sci/R&D Officer	55	21-12-31
Jonathan Eilat IRC	Investor Relations Contact	-	-
Joshua Hazenfratz AUD	Comptroller/Controller/Auditor	70	07-05-14
Iris Sadeh AUD	Comptroller/Controller/Auditor	-	11-12-31

Members of the board	Title	Age	Since
Avraham Matityahu Fischer CHM	Chairman	67	03-05-08
Yuval Yanai BRD	Director/Board Member	71	15-11-17
Gad Keren BRD	Director/Board Member	73	20-02-16
Gabriel Barbash BRD	Director/Board Member	74	03-03-24
Tomer Efraim Babai BRD	Director/Board Member	39	17-12-04
Nufar Malovani BRD	Director/Board Member	46	17-11-18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	161,256,549	55,870,242 ( 34.65 %)	4,410,349 ( 2.735 %)	34.65 %

Name	Equities	%	Valuation
Ayalon Mutual Funds Ltd. 0.2400 %	376,433	0.2400 %	42 639 ILa
KSM Mutual Funds Ltd. 0.1086 %	170,387	0.1086 %	19 300 ILa
Migdal Mutual Funds Ltd. 0.0388 %	60,933	0.0388 %	6 902 ILa
Ramco Mutual Funds Management (1989) Ltd. 0.0282 %	44,239	0.0282 %	5 011 ILa
Excellence Nessuah Mutual Funds Management Ltd. 0.0233 %	36,523	0.0233 %	4 137 ILa
Halman Aldubi Mutual Funds Ltd. 0.0105 %	16,543	0.0105 %	1 874 ILa
Menora Mivtachim Mutual Funds Ltd. 0.0102 %	15,995	0.0102 %	1 812 ILa
Edmond de Rothschild Mutual Fund Management Ltd. 0.002755 %	4,321	0.002755 %	489 ILa
U-Bank Mutual Funds Ltd. 0.000427 %	669	0.000427 %	76 ILa

Name	Equities	%	Valuation
GAMIDA CELL LTD. 1.95%	2,581,746	1.95%	92,943 $

Clal Biotechnology Industries Ltd.

Triangle Building Azrieli Center 3

67023, Tel Aviv

http://www.cbi.co.il

address Clal Biotechnology Industries Ltd.

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Other Holding Companies

	1st Jan change	Capi.
INVESTOR AB	+17.11%	75.59B
KOÇ HOLDING	+58.67%	16.95B
INVESTMENT AB LATOUR	+3.89%	15.78B
AB INDUSTRIVÄRDEN	+8.12%	13.87B
L E LUNDBERGFÖRETAGEN AB	-0.31%	12.3B
HAL TRUST	+9.49%	12.04B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+6.40%	10.88B
MERITZ FINANCIAL GROUP INC.	+37.06%	10.17B
GROUPE BRUXELLES LAMBERT SA	-1.50%	9.7B

Other Holding Companies